Anti-Hu CD77 FITC

*Högerkorp CM, Borrebaeck CA: The human CD77- B cell population represents a heterogeneous subset of cells comprising centroblasts, centrocytes, and plasmablasts, prompting phenotypical revision. J Immunol. 2006 Oct 1;177 (7) :4341-9., URL: http://www.ncbi.nlm.nih.gov/pubmed/16982868 , *Senda M, Ito A, Tsuchida A, Hagiwara T, Kaneda T, Nakamura Y, Kasama K, Kiso M, Yoshikawa K, Katagiri Y, Ono Y, Ogiso M, Urano T, Furukawa K, Oshima S, Furukawa K: Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers. Biochem J. 2007 Mar 15;402 (3) :459-70., URL: https://pubmed.ncbi.nlm.nih.gov/17123352/, *Taga S, Carlier K, Mishal Z, Capoulade C, Mangeney M, Lécluse Y, Coulaud D, Tétaud C, Pritchard LL, Tursz T, Wiels J: Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood. 1997 Oct 1;90 (7) :2757-67., URL: https://pubmed.ncbi.nlm.nih.gov/9326243/, *Wiels J, Fellous M, Tursz T: Monoclonal antibody against a Burkitt lymphoma-associated antigen. Proc Natl Acad Sci U S A. 1981 Oct;78 (10) :6485-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/7031655

The rat monoclonal antibody 38.13 recognizes CD77 (globotriaosylceramide Gb3), a neutral glycosphingolipid expressed mainly on the surface of B cell populations, such as germinal center B cells and Burkitt´s lymphoma cells.